Overview Fundamentals API Earnings EOD API Sample Code Pricing

Supported exchanges /
LSE /
0WA2.LSE

Cellectis S.A. (0WA2 LSE) stock market data APIs

€2.08 0.01(0.5%) as of September 13, 2024

Price chart is built with Anychart

Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates. The company is developing ALLO-715 and ALLO-605 for the treatment of multiple myeloma; ALLO-501 to treat large B-cell lymphoma; ALLO-316, an allogeneic engineered CAR T-cell product targeting CD70; ALLO-819 to treat acute myeloid leukemia; ALLO-213 for the treatment of small cell lung cancer; and ALLO-182 to treat gastric and pancreatic cancer. It also develops UCART22 for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia; UCART123 to treat acute myeloid leukemia; UCART 20x22 for relapsed or refractory B-Cell non-hodgkin's lymphoma; and cema-cel to treat relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. The company has strategic alliances with Allogene Therapeutics, Inc. and Les Laboratoires Servier; research collaboration and exclusive license agreement with Iovance Biotherapeutics, Inc.; and joint research and collaboration, and investment agreement with AstraZeneca Holdings B.V., as well as with AstraZeneca Ireland Limited. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.

Cellectis S.A. Financial Data Overview

Prev. Close	2.07
Open	2.08
Volume	-
High	2.3031
Low	2.07
52 wk Range	0.9143-3.426
Market Cap	229 M
P/E Ratio
Shares Outstanding	0
Revenue	19 635 K
EPS	-0.2601
Dividends (Yield)
Beta	3.228

Our easy-to-use no-coding solutions help you get the data effortlessly:

Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

Prices start at $19.99/month

General: {

Code: '0WA2',

Type: 'Common Stock',

Name: 'Cellectis S.A.',

Exchange: 'LSE',

CurrencyCode: 'EUR',

CurrencyName: 'Euro',

CurrencySymbol: '€',

CountryName: 'UK',

CountryISO: 'GB',

OpenFigi: NULL,

ISIN: NULL,

CIK: NULL,

EmployerIdNumber: NULL,

FiscalYearEnd: 'December',

IPODate: NULL,

InternationalDomestic: NULL,

Sector: '',

Industry: '',

}

Cellectis S.A. Fundamental Data is available in our Financial Data APIs

Net Revenue 19 635 K
EBITDA -77 395 000
Earnings Per Share
Income Statements
Balance Sheets
Cash flows

Fundamental data package from $59.99 See full price

Get sample
of Fundamental API Data

Get Cellectis S.A. Earnings via APIs

Latest Release 2024-08-06
EPS/Forecast NaN

Calendar package from $19.99 See full price

Get sample
earnings calendar API

Get Cellectis S.A. End-of-day Data via APIs

End of Day, Intraday and Live APIs
Splits
Dividends

All world package from $19.99 See full price

Get sample
of End-of-Day API Data

Robust, powerful and easy to use

Our advantages

Prices start at
$19.99

Fast+ support 24/7 via web-chat and email

Robust, powerful and reliable data

One click API for all financial data you need

Sample code for your quick start

Ready-to-go solutions

Our easy-to-use no-coding solutions help you get the data directly to MS Excel and Google Sheets. Or download the CSV (TXT) files effortlessly with tools for Windows and Linux.

Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

Best price for all data API

Prices start at $19.99/month

All-In-One

$99.99/per month

100 000+ API requests per day
EOD Data - All World Extended
Splits and Dividends
Fundamental Data
Bonds Data
Options Data
1000+ currency pairs
1000+ cryptocurrency pairs

Do you have any questions?

support@eodhistoricaldata.com